Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 01, 2005 (Vol. 25, No. 9)

SWICZ: Swiss-Czech Proteomics Server

  • 2-D Images
  • Narrow Scope
Let’s say you’re a researcher working on Caulobacter crescentus, Streptomyces coelicolor, or Streptomyces granaticolor. You’ll probably love the SWICZ: Swiss-Czech Proteomics Server. It has proteomic databases devoted to these three organisms. These are arranged around 2-D gel images that allow users to click on a spot and learn more about the protein that migrated to that location. On the other hand, if you’re working on any other organism in biology, you’ll probably wonder why the designers of this site used such a broad title to identify a site with such a narrow scope. OK, maybe I’m being a bit harsh, but I think this site is a little misleading in what it provides. On the plus side, the information is nicely organized and the ability to learn about a protein by clicking on a spot is very useful.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »